Genome-scale screening of deubiquitinase subfamily identifies USP3 as a stabilizer of Cdc25A regulating cell cycle in cancer
- 15 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Differentiation
- Vol. 27 (11), 3004-3020
- https://doi.org/10.1038/s41418-020-0557-5
Abstract
Conventional screening methods for deubiquitinating enzymes (DUBs) have important limitations. A loss-of-function study based on the knockout of DUB genes in mammalian cells can provide an excellent model for exploring DUB function. Here, we used CRISPR-Cas9 to perform genome-scale knockout of the entire set of genes encoding ubiquitin-specific proteases (USPs), a DUB subfamily, and then systematically screened for DUBs that stabilize the Cdc25A oncoprotein. USP3 was identified as a deubiquitinase of Cdc25A. USP3 depletion reduces the Cdc25A protein level, resulting in a significant delay in cell-cycle progression, and reduces the growth of cervical tumor xenografts in nude mice. Clinically, USP3 expression is positively correlated with Cdc25A protein expression and the poorest survival in breast cancer. We envision that our DUB knockout library kit will facilitate genome-scale screening of functional DUBs for target proteins of interest in a wide range of biomedical fields.Funding Information
- National Research Foundation of Korea (2018M3A9H3022412, 2017M3A9B3061830, 2015H1D3A1036065, 2018M3A9H3022412, 2018M3A9H3022412, 2018M3A9H3022412, 2018M3A9H3022412)
This publication has 38 references indexed in Scilit:
- Phosphatases and kinases regulating CDC25 activity in the cell cycle: clinical implications of CDC25 overexpression and potential treatment strategiesMolecular and Cellular Biochemistry, 2016
- Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteinsGenome Research, 2014
- Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNAGenome Research, 2014
- Surrogate reporter-based enrichment of cells containing RNA-guided Cas9 nuclease-induced mutationsNature Communications, 2014
- Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25ANature, 2010
- Targeted genome editing in human cells with zinc finger nucleases constructed via modular assemblyGenome Research, 2009
- Cell Cycle Control by the CDC25 PhosphatasesAnti-Cancer Agents in Medicinal Chemistry, 2008
- CDC25 phosphatases in cancer cells: key players? Good targets?Nature Reviews Cancer, 2007
- The cell cycle: a review of regulation, deregulation and therapeutic targets in cancerCell Proliferation, 2003
- Dual mode of degradation of Cdc25 A phosphataseThe EMBO Journal, 2002